What does Coherus BioSciences, Inc. do?

Jun 22 2025 06:49 PM IST
share
Share Via
Coherus BioSciences, Inc. is a late-stage clinical biologics company focused on developing and commercializing biosimilar products. As of March 2025, it reported net sales of $8 million and a net loss of $47 million, with a market cap of $87.88 million.
Overview:
Coherus BioSciences, Inc. is a late-stage clinical biologics platform company engaged in developing and commercializing biosimilar products within the Pharmaceuticals & Biotechnology industry, categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 8 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: -47 Million (Quarterly Results - Mar 2025)
Market-cap: USD 87.88 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -1.17
Return on Equity: 55.85%
Price to Book: -0.48

Contact Details:
Address: 333 Twin Dolphin Dr Ste 600, REDWOOD CITY CA: 94065-1442
Tel: 1 650 6493530
Website: https://www.coherus.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Coherus BioSciences, Inc. overvalued or undervalued?
Sep 20 2025 06:27 PM IST
share
Share Via
Is Coherus BioSciences, Inc. overvalued or undervalued?
Jun 25 2025 09:05 AM IST
share
Share Via
How big is Coherus BioSciences, Inc.?
Jun 22 2025 06:05 PM IST
share
Share Via